NEW YORK — Shares of Esperion Therapeutics Inc. jumped Wednesday in their first day of trading after the drug developer raised $70 million in an initial public offering.
In midday trading, the drug developer's shares rose $1.27, or 9 percent, to $15.27, after jumping as high as $17.40 earlier in the session. Earlier, Esperion sold 5 million shares for $14 each, resulting in $70 million in proceeds.
Esperion is developing a new kind of experimental drug that would lower LDL cholesterol, commonly known as "bad" cholesterol. Roger Newton, the company's founder, executive chairman and chief scientific officer, is a co-discoverer of the cholesterol drug Lipitor, the world's top-selling drug for more than a decade.
The shares are trading on the Nasdaq under the ticker symbol "ESPR." The company is based in Plymouth, Mich.
Anda sedang membaca artikel tentang
Esperion Therapeutics shares jump in trading debut
Dengan url
http://emberemas.blogspot.com/2013/06/esperion-therapeutics-shares-jump-in.html
Anda boleh menyebar luaskannya atau mengcopy paste-nya
Esperion Therapeutics shares jump in trading debut
namun jangan lupa untuk meletakkan link
Esperion Therapeutics shares jump in trading debut
sebagai sumbernya
0 komentar:
Posting Komentar